Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16086426rdf:typepubmed:Citationlld:pubmed
pubmed-article:16086426lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16086426lifeskim:mentionsumls-concept:C0022671lld:lifeskim
pubmed-article:16086426lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:16086426lifeskim:mentionsumls-concept:C1521725lld:lifeskim
pubmed-article:16086426pubmed:issue2lld:pubmed
pubmed-article:16086426pubmed:dateCreated2006-6-12lld:pubmed
pubmed-article:16086426pubmed:abstractTextPost-transplant lymphoproliferative disease (PTLD) is a well-recognized complication of the intense immunosuppression required in solid organ and bone marrow transplant recipients. The clinical presentation is varied and can range from a benign infectious mononucleosis-like syndrome to malignant lymphoma. PTLD manifesting as multiple myeloma occurs rarely. We report the unique occurrence of Epstein-Barr virus (EBV)-associated post-transplant multiple myeloma in a 16-year-old male. In contrast to previously described cases of PTLD-myeloma type, this patient was very young, had a clear association with EBV, and an indolent clinical course.lld:pubmed
pubmed-article:16086426pubmed:languageenglld:pubmed
pubmed-article:16086426pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16086426pubmed:citationSubsetIMlld:pubmed
pubmed-article:16086426pubmed:statusMEDLINElld:pubmed
pubmed-article:16086426pubmed:monthAuglld:pubmed
pubmed-article:16086426pubmed:issn1545-5009lld:pubmed
pubmed-article:16086426pubmed:authorpubmed-author:HallTheodoreTlld:pubmed
pubmed-article:16086426pubmed:authorpubmed-author:SaidJonathanJlld:pubmed
pubmed-article:16086426pubmed:authorpubmed-author:FeigStephen...lld:pubmed
pubmed-article:16086426pubmed:authorpubmed-author:MalogolowkinM...lld:pubmed
pubmed-article:16086426pubmed:authorpubmed-author:Al-AkashSamha...lld:pubmed
pubmed-article:16086426pubmed:authorpubmed-author:TchengWendy...lld:pubmed
pubmed-article:16086426pubmed:issnTypePrintlld:pubmed
pubmed-article:16086426pubmed:volume47lld:pubmed
pubmed-article:16086426pubmed:ownerNLMlld:pubmed
pubmed-article:16086426pubmed:authorsCompleteYlld:pubmed
pubmed-article:16086426pubmed:pagination218-23lld:pubmed
pubmed-article:16086426pubmed:dateRevised2009-1-12lld:pubmed
pubmed-article:16086426pubmed:meshHeadingpubmed-meshheading:16086426...lld:pubmed
pubmed-article:16086426pubmed:meshHeadingpubmed-meshheading:16086426...lld:pubmed
pubmed-article:16086426pubmed:meshHeadingpubmed-meshheading:16086426...lld:pubmed
pubmed-article:16086426pubmed:meshHeadingpubmed-meshheading:16086426...lld:pubmed
pubmed-article:16086426pubmed:meshHeadingpubmed-meshheading:16086426...lld:pubmed
pubmed-article:16086426pubmed:meshHeadingpubmed-meshheading:16086426...lld:pubmed
pubmed-article:16086426pubmed:meshHeadingpubmed-meshheading:16086426...lld:pubmed
pubmed-article:16086426pubmed:meshHeadingpubmed-meshheading:16086426...lld:pubmed
pubmed-article:16086426pubmed:year2006lld:pubmed
pubmed-article:16086426pubmed:articleTitlePost-transplant multiple myeloma in a pediatric renal transplant patient.lld:pubmed
pubmed-article:16086426pubmed:affiliationGwynne Hazen Cherry Memorial Laboratories, Division of Pediatric Hematology-Oncology, UCLA, Los Angeles, California, USA. wtcheng@labiomed.orglld:pubmed
pubmed-article:16086426pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16086426pubmed:publicationTypeReviewlld:pubmed
pubmed-article:16086426pubmed:publicationTypeCase Reportslld:pubmed